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The Registry of Standard Biological Parts only accepts genetic parts compatible with the RFC 10 BioBrick format.
This combined assembly and submission standard requires that four unique restriction enzyme sites must not occur
in the DNA sequence encoding a part. We present evidence that this requirement places a nontrivial burden on
iGEM teams developing large and novel parts. We further argue that the emergence of inexpensive DNA synthesis
and versatile assembly methods reduces the utility of coupling submission and assembly standards and propose a
submission standard that is compatible with current quality control strategies while nearly eliminating sequence
constraints on submitted parts.
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standard biological parts, Assembly standard, Submission standardThe Registry of Standard Biological Parts (hereafter, the
Registry) aims to provide a collection of well-characterized
genetic parts (BioBricks) with defined behaviors that can
be assembled to construct complex biological devices [1].
The genetic parts sent to iGEM teams each year in the
DNA distribution kit are derived from the Registry, and
iGEM teams are expected to improve the Registry by fur-
ther characterizing existing parts and by submitting new
parts for inclusion. Here we provide evidence that current
requirements on DNA sequences for part submission may
unnecessarily impede this mission, and propose a new sub-
mission standard that would eliminate this problem while
minimally impacting current quality control protocols.
As described in BioBricks Foundation RFC 10 and as
currently used by the Registry, BioBricks constitute a com-
bined assembly and submission standard. An assembly
standard is a procedure for combining multiple biological
parts into a device encoded by a single piece of DNA. A
submission standard refers only to requirements on the* Correspondence: mhammerling@gmail.com; jbarrick@cm.utexas.edu
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unless otherwise stated.DNA sequence of a part for it to be archived and redis-
tributed by the Registry. BioBrick parts are typically sub-
mitted on the Escherichia coli plasmid pSB1C3, and they
must be flanked by defined prefix and suffix sequences
containing restriction enzyme sites for 3A assembly [2]
(Figure 1A). Critically, these reserved (or “illegal”) restric-
tion sites must not be present within the sequence of a
BioBrick for it to be compatible with RFC 10 or similar as-
sembly standards. The pSB1C3-derived plasmid can be
transformed into E. coli cells to replicate the DNA encod-
ing a part with high fidelity, and the quality and identity of
each genetic part in the Registry can be verified by restric-
tion analysis.
At the time BioBricks were introduced, restriction en-
zyme cloning was the dominant method for assembling
multiple DNA sequences into a single construct, and
E. coli was the host for nearly all synthetic biology
devices. Since the inception of RFC 10, a great variety of
new assembly methods have been developed [5,6], includ-
ing homology-based protocols using enzymes in vitro
(Gibson Cloning, Seamless Cloning), in vivo assembly
(via yeast recombination), and assembly using type II
restriction enzymes (Golden Gate Assembly). Some of
these methods can rapidly compose many parts togetheral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Figure 1 Prevalence of illegal restriction sites in Biobrick parts. (A) Restriction enzyme sites in the required BioBrick prefix and suffix
sequences for RFC 10 are depicted above the expanded prefix and suffix sites with flanking homing endonuclease sites proposed in RFC 95. The
four restriction enzyme sites EcoRI, XbaI, SpeI, and PstI contained within the BioBrick prefix and suffix must not be present within any part
submitted in RFC 10 format. RFC 95 retains the Biobrick prefix and suffix and pSB1C3 plasmid backbone, but adds the homing endonuclease sites
I-SceI and I-CeuI, which can be used for quality control. Recognition sites for the endonucleases are boxed and the cut sites are shown within the
boxes. I-SceI and I-CeuI homing endonucleases tolerate some base substitutions in these sites, so the overall sequence degeneracy is roughly
equivalent to that of a non-degenerate 10 to 12 bp restriction site [3]. (B) The probabilities of encountering at least one of the four RFC 10 BioBrick
restriction enzymes sites (colored) or at least one of the RFC 95 homing endonuclease sites (black) in random DNA sequences as a function of sequence
length are shown. The impact of variable GC content in the part sequence is depicted for the BioBrick restriction enzymes. Performing quality control for
part length with homing endonucleases would nearly eliminate the probability of an illegal site being observed in a gene-sized DNA sequence. BBF RFC
95 contains the equations used to calculate the curves [4]. (C) The total number of DNA sequences in the Registry submitted in each year with a status
of “Not Released” (lower) and the percentage of these parts that contain at least one RFC 10 illegal restriction site in their sequence (upper)
is increasing with time, suggesting a significant and growing burden in adhering to this assembly standard. Data were collected for all parts
submitted by July 29, 2013.
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http://www.jbioleng.org/content/8/1/28in a single reaction, unlike 3A assembly, which requires
multiple rounds of restriction cleavage and ligation to
concatenate parts. Many of these newer assembly methods
also have no inherent requirement that specific base se-
quences, such as restriction sites, be present or absent in
the DNA specifying a component in order for it to be
assembled with other parts. When using such methods,
there is no need for an assembly standard to be imposed
on top of a submission standard. Researchers now employ
synthetic biology approaches in many organisms, including
plants and animals, where this greater flexibility in the se-
quences of vectors and genetic parts may be beneficial [7].
As genes and gene clusters with new activities are dis-
covered and iGEM teams seek to add these parts to the
Registry, greater incidences of illegal restriction enzymesite sequences are expected to be found within the DNA
sequences of prospective parts. While the assembly stan-
dard’s requirement to remove any illegal restriction sites
present in a part may seem a minor inconvenience, cal-
culating the frequency at which restriction sites occur
reveals that compliance with the BioBrick RFC 10 (or
similar restriction enzyme-based standards) likely bur-
dens most iGEM teams wishing to submit gene-sized or
longer parts amplified from genomic sequences to the
Registry (Figure 1B). The probability of a random DNA
sequence containing at least one of the four BioBrick
restriction sites increases rapidly with sequence length,
such that a majority of parts derived from natural se-
quences >710 bp will contain a restriction site, and more





n = 44 
Yes No
No
What DNA assembly 
methods does your iGEM 
team most commonly use?
“One-pot” assembly 
methods like Gibson 
cloning.
Restriction enzyme 
cloning methods like 
3A assembly.
Has your team used site-directed 
mutagenesis to remove illegal 
restriction sites from a part to 
submit it to the Registry?
Has your team decided not to 
submit a part to the Registry 
due to the presence of illegal 
restriction sites?
Figure 2 Results of a survey sent to iGEM teams regarding illegal restriction sites. Official contacts for all of the 2013 iGEM teams were
emailed a link to an anonymous online survey. A total of 44 responses from iGEM team members and their mentors were collected and analyzed.
Alnahhas et al. Journal of Biological Engineering 2014, 8:28 Page 3 of 4
http://www.jbioleng.org/content/8/1/28analysis of parts marked “Not Released” in the Registry
—often in this category because they do not adhere to
the RFC 10 BioBrick standard and were therefore not ac-
cepted for archival and redistribution—shows that the
fraction of parts designed by recent iGEM teams that
contain an illegal site is >15% and appears to be increas-
ing (Figure 1C).
In light of these developments, we argue that it would
be beneficial to many iGEM teams and the greater bio-
logical engineering community to no longer require com-
patibility with assembly standards for a DNA part to be
deposited in the Registry. To assess user sentiment, we
surveyed the 2013 iGEM teams about their preferred as-
sembly methods and experiences with submitting parts to
the Registry (Figure 2). Though a majority of teams still
primarily used restriction enzyme cloning, 43% most com-
monly used “one-pot” assembly methods rather than re-
striction enzyme cloning, showing that many teams are
already adopting these newer methods. We found that
52% of teams surveyed have used site-directed mutagen-
esis to remove illegal restriction sites from parts, and 36%
of teams have decided not to submit a part to the Registry
due to the presence of illegal restriction sites. Thus, a siz-
able proportion of our respondents were expending time
and effort performing site-directed mutagenesis of already
functioning parts to comply with RFC 10—a substantial
burden on the productivity of teams.
The Registry needs a submission standard that main-
tains a simple and rapid method for quality control of
submitted parts. As described in RFC 95, this aim could
be accomplished by using a less restrictive submission-
only standard where homing endonuclease sites are in-
cluded outside of the BioBrick prefix and suffix sequences
[4]. Homing endonucleases recognize and cleave within
long target sequences (~15-30 base pairs) in contrast to
the short sequences (6-8 base pairs) recognized by mostcommonly used restriction enzymes. These longer recog-
nition sequences are unlikely to occur in DNA sequences
of <20 kilobases (Figure 1B), which is approximately the
limit of what can be routinely cloned into plasmids in
E. coli. By placing the homing endonuclease sites out-
side of the current BioBrick restriction enzyme sites,
new parts submitted using this standard would remain
backwards compatible with RFC 10 assembly in cases
where no BioBrick restriction sites are found in the part.
While DNA synthesis methods are advancing rapidly
[8,9], making it more economical for iGEM teams to
custom order a limited number of ready-to-use parts,
the Registry continues to play an important role in dem-
ocratizing synthetic biology by distributing a large num-
ber of parts at a much lower cost. For a genetic parts
repository and registry to remain relevant as technology
progresses, it should anticipate these changes and adapt
its methods to complement them [10]. This may include
adopting greater flexibility by decoupling DNA assembly
and submission standards, as described here, as well as
more rigorous and standardized expectations for how
the operation of genetic parts must be characterized in
order for them to be included in the Registry.
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